Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-03

Clinical Trial Update: Medication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo [Phase 2]

View source ↗

Summary

Phase 2 trial comparing CORT118335 to placebo for protracted abstinence in alcohol use disorder completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CORT118335 (CORT118335)

Snippet

Sponsor: The Scripps Research Institute | Conditions: Alcohol Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2023-02-03